Logo image of MS1.DE

MARLEY SPOON GROUP SE (MS1.DE) Stock Fundamental Analysis

Europe - FRA:MS1 - LU2380748603 - Common Stock

0.296 EUR
-0.01 (-4.52%)
Last: 10/23/2025, 7:00:00 PM
Fundamental Rating

1

Overall MS1 gets a fundamental rating of 1 out of 10. We evaluated MS1 against 55 industry peers in the Hotels, Restaurants & Leisure industry. MS1 may be in some trouble as it scores bad on both profitability and health. MS1 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MS1 had negative earnings in the past year.
In the past year MS1 has reported a negative cash flow from operations.
MS1.DE Yearly Net Income VS EBIT VS OCF VS FCFMS1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

MS1 has a worse Return On Assets (-24.80%) than 83.64% of its industry peers.
Industry RankSector Rank
ROA -24.8%
ROE N/A
ROIC N/A
ROA(3y)-36.12%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MS1.DE Yearly ROA, ROE, ROICMS1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

MS1 has a Gross Margin (49.73%) which is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for MS1 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MS1.DE Yearly Profit, Operating, Gross MarginsMS1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

MS1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
MS1 has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MS1 has a worse debt to assets ratio.
MS1.DE Yearly Shares OutstandingMS1.DE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
MS1.DE Yearly Total Debt VS Total AssetsMS1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

MS1 has an Altman-Z score of 4.86. This indicates that MS1 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.86, MS1 belongs to the top of the industry, outperforming 92.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 4.86
ROIC/WACCN/A
WACC6.63%
MS1.DE Yearly LT Debt VS Equity VS FCFMS1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 -100M -200M

2.3 Liquidity

A Current Ratio of 0.33 indicates that MS1 may have some problems paying its short term obligations.
MS1 has a worse Current ratio (0.33) than 80.00% of its industry peers.
MS1 has a Quick Ratio of 0.33. This is a bad value and indicates that MS1 is not financially healthy enough and could expect problems in meeting its short term obligations.
MS1 has a worse Quick ratio (0.22) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.22
MS1.DE Yearly Current Assets VS Current LiabilitesMS1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.04% over the past year.
MS1 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.71%.
EPS 1Y (TTM)67.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.76%
Revenue 1Y (TTM)-43.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.04%

3.2 Future

Based on estimates for the next years, MS1 will show a very strong growth in Earnings Per Share. The EPS will grow by 22.16% on average per year.
MS1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y70.16%
EPS Next 2Y35.42%
EPS Next 3Y22.16%
EPS Next 5YN/A
Revenue Next Year-17.73%
Revenue Next 2Y-9.18%
Revenue Next 3Y-4.64%
Revenue Next 5Y3.86%

3.3 Evolution

MS1.DE Yearly Revenue VS EstimatesMS1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
MS1.DE Yearly EPS VS EstimatesMS1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MS1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MS1. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MS1.DE Price Earnings VS Forward Price EarningsMS1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MS1.DE Per share dataMS1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

MS1's earnings are expected to grow with 22.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.42%
EPS Next 3Y22.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MS1!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARLEY SPOON GROUP SE

FRA:MS1 (10/23/2025, 7:00:00 PM)

0.296

-0.01 (-4.52%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-30 2025-04-30
Earnings (Next)N/A N/A
Inst Owners0.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.63M
Revenue(TTM)279.15M
Net Income(TTM)-16670000
Analysts82.86
Price Target0.75 (153.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-45.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.88%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.57
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS9.57
BVpS-2.18
TBVpS-3.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.73%
FCFM N/A
ROA(3y)-36.12%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover4.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.91%
Cap/Sales 2.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.22
Altman-Z 4.86
F-Score3
WACC6.63%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.76%
EPS Next Y70.16%
EPS Next 2Y35.42%
EPS Next 3Y22.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-43.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.04%
Revenue Next Year-17.73%
Revenue Next 2Y-9.18%
Revenue Next 3Y-4.64%
Revenue Next 5Y3.86%
EBIT growth 1Y83.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180%
EBIT Next 3Y53.37%
EBIT Next 5Y31.28%
FCF growth 1Y-297.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.27%
OCF growth 3YN/A
OCF growth 5YN/A

MARLEY SPOON GROUP SE / MS1.DE FAQ

What is the fundamental rating for MS1 stock?

ChartMill assigns a fundamental rating of 1 / 10 to MS1.DE.


Can you provide the valuation status for MARLEY SPOON GROUP SE?

ChartMill assigns a valuation rating of 1 / 10 to MARLEY SPOON GROUP SE (MS1.DE). This can be considered as Overvalued.


Can you provide the profitability details for MARLEY SPOON GROUP SE?

MARLEY SPOON GROUP SE (MS1.DE) has a profitability rating of 0 / 10.


How financially healthy is MARLEY SPOON GROUP SE?

The financial health rating of MARLEY SPOON GROUP SE (MS1.DE) is 2 / 10.